These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36371387)

  • 1. ADCK1 is a potential therapeutic target of osteosarcoma.
    Zhuo BB; Zhu LQ; Yao C; Wang XH; Li SX; Wang R; Li Y; Ling ZY
    Cell Death Dis; 2022 Nov; 13(11):954. PubMed ID: 36371387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth.
    Han Q; Yan P; Song R; Liu F; Tian Q
    Cell Death Dis; 2023 Jul; 14(7):398. PubMed ID: 37407582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.
    Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L
    Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Gαi3 as a promising target for osteosarcoma treatment.
    Bian ZJ; Shan HJ; Zhu YR; Shi C; Chen MB; Huang YM; Wang XD; Zhou XZ; Cao C
    Int J Biol Sci; 2022; 18(4):1508-1520. PubMed ID: 35280670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo.
    Kong Y; Li X; Zhang H; Fu B; Jiang HY; Yang HL; Dai J
    Cell Death Dis; 2024 Jan; 15(1):57. PubMed ID: 38228583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histone acetyltransferase HBO1 functions as a novel oncogenic gene in osteosarcoma.
    Gao YY; Ling ZY; Zhu YR; Shi C; Wang Y; Zhang XY; Zhang ZQ; Jiang Q; Chen MB; Yang S; Cao C
    Theranostics; 2021; 11(10):4599-4615. PubMed ID: 33754016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Sun H; Yin M; Qian W; Yin H
    Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma.
    Yin DP; Zheng YF; Sun P; Yao MY; Xie LX; Dou XW; Tian Y; Liu JS
    Cell Death Dis; 2022 Mar; 13(3):210. PubMed ID: 35246508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth.
    Xia Y; He C; Hu Z; Wu Z; Hui Y; Liu YY; Mu C; Zha J
    Int J Biol Sci; 2023; 19(6):1778-1790. PubMed ID: 37063426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer.
    Peng SQ; Zhu XR; Zhao MZ; Zhang YF; Wang AR; Chen MB; Ye ZY
    Cell Death Dis; 2023 Feb; 14(2):157. PubMed ID: 36828810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Gαi3 as a novel molecular therapeutic target of cervical cancer.
    Zhang J; Yin DP; Zhang Y; Zhang JN; Yang Y; Zhang ZQ; Zhou L; Lv Y; Huang HW; Cao C
    Int J Biol Sci; 2022; 18(15):5667-5680. PubMed ID: 36263185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC.
    Zhang JZ; Liu J; Xu YX; Pu WY; Shen MJ; Jiang KQ; Yang YL; Lu J; Deng Z; Yang Y; Xu WH
    Int J Biol Sci; 2022; 18(16):6163-6175. PubMed ID: 36439873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIMM44 is a potential therapeutic target of human glioma.
    Guo YZ; Chen G; Huang M; Wang Y; Liu YY; Jiang Q; Cao C; Liu F
    Theranostics; 2022; 12(17):7586-7602. PubMed ID: 36438483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The requirement of the mitochondrial protein NDUFS8 for angiogenesis.
    Xiong QW; Jiang K; Shen XW; Ma ZR; Yan XM; Xia H; Cao X
    Cell Death Dis; 2024 Apr; 15(4):253. PubMed ID: 38594244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual mTORC1/2 inhibition by INK-128 results in antitumor activity in preclinical models of osteosarcoma.
    Jiang H; Zeng Z
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):255-61. PubMed ID: 26514724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer.
    Li X; Yao L; Wang T; Gu X; Wu Y; Jiang T
    Cell Death Dis; 2023 Oct; 14(10):665. PubMed ID: 37816734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR: An attractive therapeutic target for osteosarcoma?
    Ding L; Congwei L; Bei Q; Tao Y; Ruiguo W; Heze Y; Bo D; Zhihong L
    Oncotarget; 2016 Aug; 7(31):50805-50813. PubMed ID: 27177330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth.
    Cui Z; Mu C; Wu Z; Pan S; Cheng Z; Zhang ZQ; Zhao J; Xu C
    Cell Death Dis; 2022 Jun; 13(6):569. PubMed ID: 35760803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
    Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of mitochondrial RNA polymerase as a potential therapeutic target of osteosarcoma.
    Han QC; Zhang XY; Yan PH; Chen SF; Liu FF; Zhu YR; Tian Q
    Cell Death Discov; 2021 Dec; 7(1):393. PubMed ID: 34907167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.